Listed below are the current guidelines, provisional clinical opinions, endorsements, and updates in development. Topics prioritized for development by the Clinical Practice Guidelines Committee and Guideline Advisory Groups are listed by disease site. To submit a topic for consideration, take our survey. To learn more about the ASCO Guideline development process, access the Guideline Methodology page.
Guidelines/Provisional Clinical Opinions (PCOs)/Endorsements in Development
Breast Cancer
- Management of the Breast Axilla
- Neoadjuvant Therapy for Breast Cancer
- Update: Chemo- and Targeted Therapy for Women with HER2 Negative (or unknown) Advanced Breast Cancer
Gastrointestinal Cancer
- Management of Localized and Locally Advanced Esophageal Adenocarcinoma and Squamous Cell Carcinoma
- Systemic Therapy for Advanced Hepatocellular Carcinoma
- Update: Stage II Colon Cancer
Genitourinary Cancer
- Special Considerations for Elderly Patients with Genitourinary Cancers
- Update: Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer
- Update: Muscle-invasive and Metastatic Bladder Cancer
Head and Neck Cancer
- Management of Salivary Gland Malignancy
Neurooncology
- Treatment of Patients with Brain Metastases
- Therapy for Diffuse Astrocytic and Oligodendroglial Tumors
Resource Stratified
- Treatment of Ovarian Cancer
Supportive Care
- Salivary Gland Hypofunction
- Diet & Exercise During Active Cancer Treatment
- Update: Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer
- Update: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy
Survivorship
- Cognitive Dysfunction in Cancer Survivors
- Update: Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer Guideline Adaptation
- Update: Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer Guideline Adaptation
Thoracic
- Management of Stage III NSCLC
- Update: Therapy for Stage IV Non–Small-Cell Lung Cancer with Driver Alterations Update
Multi-Site
- Somatic Genomic Panel Testing for Metastatic Disease
Guideline Priorities 2019-2020
Breast Cancer
- Management of Older-Age Breast Cancer Patients with Early-Stage Breast Cancer
- Management of Breast Cancer in Pregnant Patients
- Germline Testing Among Women with a Personal History of Breast Cancer
- Advanced Imaging and Standards for Patients at High Risk with Breast Carcinoma
- Role of Adjuvant Radiation Therapy After Lumpectomy in DCIS Patients
- Update: Breast Cancer Follow-Up and Management After Primary Treatment
- Update: Postmastectomy Radiotherapy
- Update: Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer
Gastrointestinal Cancer
- Systemic Therapy for Advanced Gastroesophageal Cancer
- Treatment Options for Well-Differentiated Neuroendocrine Tumors
- Management of Perioperative Gastric Cancer
- Neoadjuvant and Adjuvant Therapy for Rectal Cancer, Including Watchful Waiting
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Local Therapy for Metastatic Colorectal Cancer
Genitourinary Cancer
- Management of Metastatic Renal Clear Cell Cancer
- Management of Newly Diagnosed Clinical and Pathologic Node-Positive Prostate Cancer
- Penile Cancer
- Germline Genetic Testing for Prostate Cancer
- Primary Tumor-Directed and Metastasis-Directed Local Therapy in Oligometastatic Prostate Cancer
- Update: Muscle-Invasive and Metastatic Bladder Cancer
Gynecologic Cancer
- First Platinum-Sensitive Ovarian Cancer Recurrence
- Adjuvant Therapy for High-Risk Endometrial Cancer Patients
- Chemotherapy for Women With Advanced-Stage Ovarian/Primary Peritoneal/Fallopian Tube Cancer Following Upfront Surgical Cytoreduction
- Front-Line Maintenance in Ovarian Cancer
- Update: Neoadjuvant Chemotherapy for Ovarian Cancer
Head and Neck Cancer
- Use of Immune Checkpoint Inhibitors and PD-L1 Testing in Head and Neck Squamous Cell Carcinoma, Focusing on Recurrent/Metastatic Disease
- Management of Locoregionally Recurrent Head and Neck Cancer Including Re-Irradiation
- Use of Systemic Treatment in the Management of Advanced Thyroid Cancer
- Pre-operative Decision-making and Its Impact on Function and Adjuvant Therapy in Transoral Endoscopic Head and Neck Surgery
- Definitive Management of Locoregionally Advanced Nasopharyngeal Cancer
Multi-Site
- Germline Genetic Testing
- Adjuvant Therapy for Soft-Tissue Sarcoma
- Management of Untreated Follicular Lymphoma
- Chronic Lymphocytic Leukemia
- Treatment of Oligometastatic Disease
Resource Stratified
- Treatment of Patients with Metastatic Breast Cancer, including HER2+
- Survivorship Care in Adolescents, Young Adults, and Adults
- Geriatric Oncology
- Update: Secondary Prevention of Cervical Cancer Resource-Stratified Guideline
Supportive Care
- Cannabis for Palliative Care
- Communication Regarding Prognosis and Life Expectancy
- Financial Toxicities
- Update: Integration of Palliative Care into Standard Oncology Care
- Update: Central Venous Catheter Care for the Patient With Cancer
Survivorship
- Exercise, Weight, and Obesity in Post-Treatment Cancer Survivors
- Management of Lymphedema in Cancer Survivors
- Management of Sleep Problems in Cancer Survivors
- AYA Cancer Survivorship
- Survivorship After Stem Cell Transplantation
Thoracic
- Molecular Profiling for Predictive Biomarkers in Non-Small-Cell Lung Cancer
- Systemic Therapy for Small Cell Lung Cancer
- Management of Oligometastasis and Oligoprogressive Disease
Recently Published Guidelines
- Update: Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
- Metastatic Carcinoma and Myeloma of the Femur
- PARP Inhibitors for Ovarian Cancer
- Update: Metastatic Pancreatic Cancer
- Update: Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy
- Update: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers
- Update: Antiemetics
- Treatment of Locally Advanced Esophageal Carcinoma
- Management of Cancer Cachexia
- Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
- Management of Hereditary Breast Cancer
- Systemic Therapy for Melanoma
- Treatment of Patients with Late-Stage Colorectal Resource-Stratified Guideline
- Management of Male Breast Cancer
- Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations
- Bone Health and Bone-targeted Therapies for Prostate Cancer
- Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
- Optimum Imaging Strategies for Advanced Prostate Cancer
- Estrogen and Progesterone Receptor Testing in Breast Cancer
- Lung Cancer Surveillance After Definitive Curative-Intent Therapy
- Molecular Biomarkers in Localized Prostate Cancer
- Patient-Centered Standards for Medically Integrated Dispensing
- Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease
- Use of Endocrine Therapy for Breast Cancer Risk Reduction
- Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
- Medication-Related Osteonecrosis of the Jaw
- Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer
- Potentially Curable Pancreatic Adenocarcinoma
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx
- Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer
- Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer